Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            May 26, 2022
            Published by admin on May 26, 2022
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine

            ROCKVILLE, Md., May 26, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help […]
            Do you like it?0
            Read more
            May 26, 2022
            Published by admin on May 26, 2022
            Categories
            • In Vitro Diagnostics - IVD News

            Neonatal Diagnostics Company InfanDx AG Completes Two-Year Patient Follow-Up in BANON Study

            Cologne, Germany, and Boston, MA, USA, May 25, 2022 – InfanDx AG, a privately held diagnostics company focusing on the development and commercialization of novel diagnostic solutions […]
            Do you like it?0
            Read more
            April 17, 2022
            Published by admin on April 17, 2022
            Categories
            • In Vitro Diagnostics - IVD News

            Neonatal Diagnostics Company InfanDx AG Launches US Operations

            April 12, 2022 04:00 ET | Source: AKAMPION Cologne, Germany, and Boston, MA, USA, April 12, 2022 – InfanDx AG, a privately-held diagnostics company focusing on the development and commercialization […]
            Do you like it?0
            Read more
            April 5, 2022
            Published by admin on April 5, 2022
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Interim Analysis Results from Clinical Trial for Unyvero Urinary Tract Infection Panel

            Download PDF Interim analysis performed with initial 150 U.S. patient samples enrolled in its prospective multicenter trial for the Unyvero UTI panel – Clinical Trial to […]
            Do you like it?0
            Read more
            October 4, 2021
            Published by admin on October 4, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Receives FDA Clearance for Acuitas® AMR Gene Panel

            ROCKVILLE, Md., Oct. 04, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, […]
            Do you like it?0
            Read more
            October 1, 2021
            Published by admin on October 1, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Initiates Clinical Trial for Unyvero Urinary Tract Infection (UTI) Panel

            ROCKVILLE, Md., Sept. 30, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, […]
            Do you like it?0
            Read more
            September 16, 2021
            Published by admin on September 16, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Data from Prospective Randomized Controlled Multicenter Clinical Study Using the Unyvero HPN Panel for Hospitalized Patients with Suspicion of Pneumonia

            ROCKVILLE, Md., Sept. 15, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to […]
            Do you like it?0
            Read more
            August 9, 2021
            Published by admin on August 9, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            GBC Contributes to NCI – CPTAC Publication: A Proteogenomic Portrait of Lung Squamous Cell Carcinoma

            Published in: CELL | VOLUME 184, ISSUE 16, P4348-4371.E40, AUGUST 05, 2021 Download: PDF [20 MB] Comprehensive proteogenomic characterization of lung squamous cell carcinomas and paired normal adjacent tissues […]
            Do you like it?0
            Read more
            August 3, 2021
            Published by admin on August 3, 2021
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Achieves Key Development Milestone with Curetis Unyvero A30 RQ Platform Program

            ROCKVILLE, Md., Aug. 03, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, […]
            Do you like it?0
            Read more
            Prev page
            1234567891011121314
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕